Zymeworks, Inc. (ZYME)
23.63
+0.64
(+2.78%)
USD |
NASDAQ |
Feb 24, 16:00
23.62
-0.01
(-0.04%)
After-Hours: 20:00
Zymeworks Total Assets (Quarterly) : 397.27M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| BioLife Solutions, Inc. | 392.08M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 77.20M |
| Shareholders Equity (Quarterly) | 320.06M |
| Debt to Equity Ratio | 0.0591 |
| Current Ratio | 6.938 |
| Net Debt Paydown Yield | 0.02% |